Shares of AstraZeneca Pharma India declined more than 4% in early trade on May 27 after the company reported a mixed set of fourth-quarter earnings, with revenue growth offset by pressure on profitability margins.
As of 9:48 AM IST, AstraZeneca Pharma shares were trading near the day’s low after opening at Rs 8,826.00 against the previous close of Rs 8,962.50. The stock touched an intraday low of Rs 8,482.00 and a high of Rs 8,826.00. The company’s 52-week high stands at Rs 10,691.00, while the 52-week low is Rs 7,551.50.
AstraZeneca Pharma Q4 Results
For the quarter ended March 2026, the company reported revenue of Rs 579 crore, registering a 20.4% year-on-year increase compared to Rs 481 crore in the corresponding quarter last year.
However, EBITDA fell 29.5% to Rs 60.9 crore from Rs 86.4 crore in the year-ago period. EBITDA margin also contracted sharply to 10.5% from 18.0% on a YoY basis.
Net profit declined 23.0% to Rs 44.9 crore versus Rs 58.3 crore reported in the same quarter previous year.
Disclaimer: This article is for informational purposes only and should not be considered as investment advice. Stock market investments are subject to market risks. Readers are advised to consult certified financial advisors before making any investment decisions. The data and figures mentioned are based on company filings and publicly available information. Past performance does not guarantee future returns. Neither the author nor the publisher is responsible for any losses arising from investment decisions based on this article.